{"id":"https://openalex.org/W2018444971","doi":"https://doi.org/10.2174/157016207782418461","title":"Transmission of HIV-1 in the Face of Neutralizing Antibodies","display_name":"Transmission of HIV-1 in the Face of Neutralizing Antibodies","publication_year":2007,"publication_date":"2007-11-01","ids":{"openalex":"https://openalex.org/W2018444971","doi":"https://doi.org/10.2174/157016207782418461","mag":"2018444971","pmid":"https://pubmed.ncbi.nlm.nih.gov/18045114"},"language":"en","primary_location":{"id":"doi:10.2174/157016207782418461","doi":"https://doi.org/10.2174/157016207782418461","is_oa":false,"landing_page_url":"https://doi.org/10.2174/157016207782418461","pdf_url":null,"source":{"id":"https://openalex.org/S203872900","display_name":"Current HIV Research","issn_l":"1570-162X","issn":["1570-162X","1873-4251"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current HIV Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080080229","display_name":"Catherine A. Blish","orcid":"https://orcid.org/0000-0001-6946-7627","observed_orcids":["https://orcid.org/0000-0001-6946-7627"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Blish","raw_affiliation_strings":["Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. cblish@fhcrc.org","Fred Hutchinson Cancer Research Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. cblish@fhcrc.org","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028119289","display_name":"Wendy Blay Puryear","orcid":"https://orcid.org/0000-0002-1795-3399","observed_orcids":["https://orcid.org/0000-0002-1795-3399"]},"institutions":[{"id":"https://openalex.org/I1294824412","display_name":"Center for Infectious Disease Research","ror":"https://ror.org/04jkbnw46","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1294824412"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy Blay","raw_affiliation_strings":["Seattle Biomedical Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Biomedical Research Institute","institution_ids":["https://openalex.org/I1294824412"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061909491","display_name":"Nancy Logan Haigwood","orcid":"https://orcid.org/0000-0002-1477-9575","observed_orcids":["https://orcid.org/0000-0002-1477-9575"]},"institutions":[{"id":"https://openalex.org/I1294824412","display_name":"Center for Infectious Disease Research","ror":"https://ror.org/04jkbnw46","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1294824412"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Haigwood","raw_affiliation_strings":["Seattle Biomedical Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Biomedical Research Institute","institution_ids":["https://openalex.org/I1294824412"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075328638","display_name":"Julie M. Overbaugh","orcid":"https://orcid.org/0000-0002-0239-9444","observed_orcids":["https://orcid.org/0000-0002-0239-9444"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Overbaugh","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center","institution_ids":["https://openalex.org/I4210089486"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3048,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.76223041,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"5","issue":"6","first_page":"578","last_page":"587"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-transmission","display_name":"HIV-1 transmission","score":0.996999979019165},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.953000009059906},{"id":"https://openalex.org/keywords/sexual-transmission","display_name":"sexual transmission","score":0.7099999785423279},{"id":"https://openalex.org/keywords/mother-to-child-transmission","display_name":"mother-to-child transmission","score":0.8920000195503235},{"id":"https://openalex.org/keywords/superinfection","display_name":"superinfection","score":0.9729999899864197},{"id":"https://openalex.org/keywords/subtype-c","display_name":"subtype C","score":0.6620000004768372},{"id":"https://openalex.org/keywords/discordant-couples","display_name":"discordant couples","score":0.5440000295639038},{"id":"https://openalex.org/keywords/antibody-resistance","display_name":"antibody resistance","score":0.36399999260902405},{"id":"https://openalex.org/keywords/selective-pressure","display_name":"selection pressure","score":0.3580000102519989},{"id":"https://openalex.org/keywords/hiv-vaccine-design","display_name":"HIV vaccine design","score":0.6050000190734863},{"id":"https://openalex.org/keywords/prophylaxis","display_name":"prophylaxis","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6589611768722534},{"id":"https://openalex.org/C761482","wikidata":"https://www.wikidata.org/wiki/Q118093","display_name":"Transmission (telecommunications)","level":2,"score":0.5609252452850342},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5487788319587708},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5454410314559937},{"id":"https://openalex.org/C2779304628","wikidata":"https://www.wikidata.org/wiki/Q3503480","display_name":"Face (sociological concept)","level":2,"score":0.5331684350967407},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.45927008986473083},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36272913217544556},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2449721395969391},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.22528526186943054},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.15790316462516785},{"id":"https://openalex.org/C76155785","wikidata":"https://www.wikidata.org/wiki/Q418","display_name":"Telecommunications","level":1,"score":0.13723793625831604},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.07659578323364258},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015483","descriptor_name":"HIV Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000635","qualifier_name":"transmission","is_major_topic":true},{"descriptor_ui":"D018445","descriptor_name":"Infectious Disease Transmission, Vertical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018562","descriptor_name":"Disease Transmission, Infectious","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/157016207782418461","doi":"https://doi.org/10.2174/157016207782418461","is_oa":false,"landing_page_url":"https://doi.org/10.2174/157016207782418461","pdf_url":null,"source":{"id":"https://openalex.org/S203872900","display_name":"Current HIV Research","issn_l":"1570-162X","issn":["1570-162X","1873-4251"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current HIV Research","raw_type":"journal-article"},{"id":"pmid:18045114","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18045114","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current HIV research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1063528380","display_name":"Role of Neutralizing Antibodies in Transmission of SHIV","funder_award_id":"R01HD038653","funder_id":"https://openalex.org/F4320337611","funder_display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development"},{"id":"https://openalex.org/G2065977398","display_name":"Novel antigen display system to present multiple antigens HIV vaccines","funder_award_id":"R01AI074379","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G2152835779","display_name":null,"funder_award_id":"AI38518","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G3560409608","display_name":"Combined Approach to Broadly Protective AIDS Vaccines","funder_award_id":"P01AI054564","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G5412119927","display_name":"Defining Immune Deficits in HIV-1 Infected Women","funder_award_id":"K08AI068424","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G5532058306","display_name":null,"funder_award_id":"R01 HD38653-06","funder_id":"https://openalex.org/F4320337611","funder_display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development"},{"id":"https://openalex.org/G5619662716","display_name":"E2 Display as a candidate AIDS vaccine","funder_award_id":"R21AI062418","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337611","display_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","ror":"https://ror.org/04byxyr05"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2036549279","https://openalex.org/W2154805031","https://openalex.org/W7095860742","https://openalex.org/W2095497026","https://openalex.org/W2259576691","https://openalex.org/W2167983396","https://openalex.org/W2040698214","https://openalex.org/W2135386401","https://openalex.org/W2144539981","https://openalex.org/W7025180005"],"abstract_inverted_index":{"In":[0,70],"most":[1],"cases":[2,203],"of":[3,9,25,39,48,63,73,116,120,137,148,155,204,214,223],"HIV-1":[4,100],"transmission,":[5,75],"only":[6],"a":[7,113],"subset":[8],"variants":[10,28,50,76,94,163,180],"is":[11],"transmitted":[12,27,49,93,117,217],"from":[13,95,178,236],"the":[14,18,23,37,43,56,67,71,135,144,149,153,176,185,212,215,219,229,247],"index":[15],"case":[16],"to":[17,35,82,123,141,167,184,192,234],"newly":[19],"infected":[20],"individual.":[21],"Understanding":[22],"characteristics":[24,213],"these":[26,207],"may":[29,110,242],"aid":[30],"in":[31,87,160,202,218],"developing":[32],"new":[33,156],"methods":[34],"halt":[36],"spread":[38],"HIV-1.":[40],"Studies":[41,119],"evaluating":[42],"genotypic":[44],"and":[45,99,127,146,221,240,256],"antigenic":[46],"properties":[47],"have":[51],"provided":[52],"insights":[53,245],"into":[54,246],"how":[55],"selective":[57],"pressures":[58],"applied":[59],"during":[60,85,238],"different":[61,96],"modes":[62],"transmission":[64,86,125],"uniquely":[65],"imprint":[66],"infecting":[68],"viruses.":[69],"setting":[72],"sexual":[74],"with":[77],"increased":[78,105],"neutralization":[79,106],"sensitivity":[80],"appeared":[81],"be":[83,112],"selected":[84],"discordant":[88],"subtype":[89],"C-infected":[90],"couples,":[91],"although":[92,206],"risk":[97],"groups":[98],"subtypes":[101],"did":[102],"not":[103,111],"demonstrate":[104],"sensitivity,":[107],"suggesting":[108,170],"this":[109],"consistent":[114],"feature":[115],"variants.":[118],"both":[121],"mother":[122],"child":[124],"(MTCT)":[126],"superinfection,":[128,205],"where":[129],"preexisting":[130],"NAbs":[131,224],"are":[132,182,189,200,209,251],"present":[133,201],"at":[134],"time":[136],"exposure,":[138],"provide":[139,243],"opportunities":[140],"analyze":[142],"whether":[143],"breadth":[145],"potency":[147],"NAb":[150,230],"response":[151],"influence":[152],"incidence":[154],"infections.":[157],"MTCT":[158,239],"resulted":[159],"selection":[161],"for":[162,253],"that":[164,171,181,194,232,250],"were":[165],"resistant":[166],"maternal":[168,172],"antibodies,":[169],"antibodies":[173,186],"can":[174],"protect":[175,235],"baby":[177],"those":[179],"susceptible":[183],"present.":[187],"There":[188],"some":[190],"data":[191,208],"suggest":[193],"poor":[195],"neutralizing":[196],"antibody":[197,248],"(NAb)":[198],"responses":[199,231,249],"preliminary.":[210],"Defining":[211],"viruses":[216],"presence":[220],"absence":[222],"as":[225,227],"well":[226],"defining":[228],"fail":[233],"infection":[237],"superinfection":[241],"critical":[244],"needed":[252],"effective":[254],"vaccines":[255],"other":[257],"prophylactic":[258],"therapeutics.":[259]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":6},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}